HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

KMTS

Kestra Medical Technologies, Ltd. (NASDAQ)

Healthcare — Medical Instruments & Supplies

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

None 7 analysts
$26.28
+$0.84 (+3.30%)
Target: $27.71 (5.5%)
Sign in to add KMTS to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$1.53B
P/E Ratio (TTM)-
Forward P/E-12.28
EPS (TTM)$-5.46
Dividend Yield-
Profit Margin-172.99%
Revenue Growth62.70%
ROE-92.65%
Debt/Equity16.16
Recommendation None
Analyst Target$27.71
Analysts7
Indexes NASDAQ

Technical Indicators

RSI (14)77.1
Beta-
SMA 20-
SMA 40-
52-Week High$30.00
52-Week Low$13.25
50-Day Avg$21.27
200-Day Avg$23.51
Avg Volume313.2K
Volume744.6K

Performance Analysis

BULLISH

KMTS shows predominantly bullish signals based on its fundamentals and technicals.

+ Showing strength at 78% of its 52-week range.
- RSI at 77.1 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
+ Strong revenue growth of 62.7% year-over-year.
- Operating at a loss with -173.0% margin.
~ Wall Street consensus is "none" from 7 analysts.
+ Average analyst target of $27.71 implies 5.5% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:17 UTC

Back to Screener Export Report